12,897 Shares of Align Technology, Inc. $ALGN Bought by Impax Asset Management Group plc

Impax Asset Management Group plc acquired a new position in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 12,897 shares of the medical equipment provider’s stock, valued at approximately $1,875,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in Align Technology in the 2nd quarter valued at about $745,370,000. Assenagon Asset Management S.A. increased its stake in Align Technology by 638.7% in the third quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock valued at $629,469,000 after purchasing an additional 4,031,284 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in Align Technology by 3,162.7% in the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock worth $278,342,000 after buying an additional 2,033,451 shares during the last quarter. Vontobel Holding Ltd. grew its holdings in Align Technology by 69,628.9% in the third quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider’s stock valued at $183,335,000 after purchasing an additional 1,383,526 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its holdings in Align Technology by 4.9% in the first quarter. Arrowstreet Capital Limited Partnership now owns 1,054,633 shares of the medical equipment provider’s stock valued at $180,796,000 after purchasing an additional 49,220 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Mizuho cut their target price on Align Technology from $220.00 to $200.00 and set an “outperform” rating on the stock in a research report on Thursday, October 22nd. Evercore lowered shares of Align Technology from an “outperform” rating to an “in-line” rating and set a $155.00 price target on the stock. in a report on Monday, October 5th. Weiss Ratings raised shares of Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 9th. Wall Street Zen lowered shares of Align Technology from a “buy” rating to a “hold” rating in a research report on Saturday, October 24th. Finally, Raymond James Financial restated a “buy” rating on shares of Align Technology in a report on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $193.08.

Get Our Latest Stock Analysis on Align Technology

Align Technology Price Performance

Shares of ALGN stock opened at $159.68 on Friday. The firm has a fifty day moving average of $152.42 and a two-hundred day moving average of $168.55. The firm has a market cap of $11.26 billion, a P/E ratio of 17.57, a P/E/G ratio of 2.13 and a beta of 1.74. Align Technology, Inc. has a 1-year low of $132.63 and a 1-year high of $200.43.

Align Technology (NASDAQ:ALGN – Get Free Report) last issued its earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.77 by $0.03. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. During the same quarter in the prior year, the business posted $2.61 EPS. The company’s revenue for the quarter was up 1.9% on a year-over-year basis. On average, sell-side analysts expect that Align Technology, Inc. will post 9.21 EPS for the current year.

About Align Technology

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

Featured Articles

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.